<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Authors report their favourable experience concerning the treatment of five cases of <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> with high-dose intravenous immunoglobulins: three cases of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> with <z:hpo ids='HP_0000123'>nephritis</z:hpo>, hematological involvement and <z:hpo ids='HP_0001945'>fever</z:hpo>; one case of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo>-associated pregnancy; and one case of <z:e sem="disease" ids="C0263666" disease_type="Disease or Syndrome" abbrv="">juvenile dermatomyositis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Disease manifestations had proved refractory to previous conventional and sometimes aggressive therapies in <z:hpo ids='HP_0000001'>all</z:hpo> the patients </plain></SENT>
<SENT sid="2" pm="."><plain>The results obtained are discussed on the basis of more recent data from the literature </plain></SENT>
<SENT sid="3" pm="."><plain>Further investigation in the treatment of <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue diseases</z:e> with intravenous immunoglobulins is suggested </plain></SENT>
<SENT sid="4" pm="."><plain>However, this therapy should be employed only in carefully selected patients </plain></SENT>
</text></document>